238 related articles for article (PubMed ID: 29309244)
1. Successful Treatment of Refractory Type 1 Pityriasis Rubra Pilaris With Apremilast.
Molina-Figuera E; González-Cantero Á; Martínez-Lorenzo E; Sánchez-Moya AI; García-Olmedo O; Gómez-Dorado B; Schoendorff-Ortega C
J Cutan Med Surg; 2018; 22(1):104-105. PubMed ID: 29309244
[No Abstract] [Full Text] [Related]
2. A Case of Pityriasis Rubra Pilaris Treated Successfully with the Phosphodiesterase-4 Inhibitor Apremilast.
Cho M; Honda T; Ueshima C; Kataoka T; Otsuka A; Kabashima K
Acta Derm Venereol; 2018 Nov; 98(10):975-976. PubMed ID: 29944172
[No Abstract] [Full Text] [Related]
3. Patient experiences with biologics and apremilast in pityriasis rubra pilaris: A patient survey.
Maloney NJ; Kim MM; Nguyen KA; Hisaw LD; Worswick S
Dermatol Ther; 2019 Sep; 32(5):e13060. PubMed ID: 31397958
[No Abstract] [Full Text] [Related]
4. Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast.
Krase IZ; Cavanaugh K; Curiel-Lewandrowski C
JAMA Dermatol; 2016 Mar; 152(3):348-50. PubMed ID: 26536384
[No Abstract] [Full Text] [Related]
5. A case of severe pityriasis rubra pilaris with a dramatic response to apremilast.
Pellonnet L; Beltzung F; Franck F; Rouanet J; D'incan M
Eur J Dermatol; 2018 Feb; 28(1):128-129. PubMed ID: 29400288
[No Abstract] [Full Text] [Related]
6. Successful use of etanercept in type I pityriasis rubra pilaris.
Seckin D; Tula E; Ergun T
Br J Dermatol; 2008 Mar; 158(3):642-4. PubMed ID: 18081896
[No Abstract] [Full Text] [Related]
7. Pityriasis rubra pilaris: a review of diagnosis and treatment.
Cohen PR; Prystowsky JH
J Am Acad Dermatol; 1989 May; 20(5 Pt 1):801-7. PubMed ID: 2654219
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
Boyd AH; Polcari IC
Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
[TBL] [Abstract][Full Text] [Related]
9. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
[TBL] [Abstract][Full Text] [Related]
10. Pityriasis rubra pilaris, type 1.
Booth AV; Ma L
Dermatol Online J; 2005 Dec; 11(4):9. PubMed ID: 16403381
[TBL] [Abstract][Full Text] [Related]
11. [Pityriasis rubra pilaris : Successful treatment with ixekizumab].
Kohn D; Wetzig T
Hautarzt; 2020 Aug; 71(8):624-626. PubMed ID: 32185430
[TBL] [Abstract][Full Text] [Related]
12. Pityriasis rubra pilaris types 1 and 2: different responses to treatment with TNF-alpha antagonists.
Vujic I; Richter L; Bartsch K; Monshi B; Rappersberger K
Eur J Dermatol; 2013; 23(6):895-6. PubMed ID: 24192269
[No Abstract] [Full Text] [Related]
13. Oral pityriasis rubra pilaris.
Martinez Calixto LE; Suresh L; Matsumura E; Aguirre A; Radfar L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 May; 101(5):604-7. PubMed ID: 16632271
[TBL] [Abstract][Full Text] [Related]
14. Pityriasis rubra pilaris.
White KL
Dermatol Online J; 2003 Oct; 9(4):6. PubMed ID: 14594579
[TBL] [Abstract][Full Text] [Related]
15. [Pityriasis rubra pilaris].
Wollina U
Hautarzt; 2012 Aug; 63(8):655-61; quiz 662. PubMed ID: 22825756
[TBL] [Abstract][Full Text] [Related]
16. Pityriasis rubra pilaris heralding diagnosis of urothelial carcinoma: a case report.
Young PA; Rangel J; Keller LC
Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259857
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
Wassef C; Lombardi A; Rao BK
Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
[TBL] [Abstract][Full Text] [Related]
18. Surgical Management of Cicatricial Ectropion in Pityriasis Rubra Pilaris.
Haridas AS; Sullivan TJ
Ophthalmic Plast Reconstr Surg; 2016; 32(1):e12-5. PubMed ID: 25794020
[TBL] [Abstract][Full Text] [Related]
19. Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.
Boudreaux BW; Pincelli TP; Bhullar PK; Patel MH; Brumfiel CM; Li X; Heckman MG; Pittelkow MR; Mangold AR; Sluzevich JC
Br J Dermatol; 2022 Nov; 187(5):650-658. PubMed ID: 35701384
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of pityriasis rubra pilaris under efalizumab therapy.
Klein A; Szeimies RM; Landthaler M; Karrer S
Dermatology; 2007; 215(1):72-5. PubMed ID: 17587845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
